ES2041845T3 - Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos. - Google Patents

Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos.

Info

Publication number
ES2041845T3
ES2041845T3 ES198989101215T ES89101215T ES2041845T3 ES 2041845 T3 ES2041845 T3 ES 2041845T3 ES 198989101215 T ES198989101215 T ES 198989101215T ES 89101215 T ES89101215 T ES 89101215T ES 2041845 T3 ES2041845 T3 ES 2041845T3
Authority
ES
Spain
Prior art keywords
acetamide
oxo
determination
pirrolidon
glomerular filtration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989101215T
Other languages
English (en)
Inventor
H.-U. Prof. Dr. Med. Habil. Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Cassella AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG filed Critical Cassella AG
Application granted granted Critical
Publication of ES2041845T3 publication Critical patent/ES2041845T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

UTILIZACION DE 2 - OXO - PIRROLIDIN - 1 - ACETAMIDA PARA DEETERMINAR LA TASA DE FILTRACION GLOMERULAR EN EL HOMBRE.
ES198989101215T 1988-02-02 1989-01-25 Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos. Expired - Lifetime ES2041845T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3802996A DE3802996A1 (de) 1988-02-02 1988-02-02 Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen

Publications (1)

Publication Number Publication Date
ES2041845T3 true ES2041845T3 (es) 1993-12-01

Family

ID=6346429

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989101215T Expired - Lifetime ES2041845T3 (es) 1988-02-02 1989-01-25 Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos.

Country Status (6)

Country Link
US (1) US4908202A (es)
EP (1) EP0329961B1 (es)
JP (1) JPH01226829A (es)
AT (1) ATE77560T1 (es)
DE (2) DE3802996A1 (es)
ES (1) ES2041845T3 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5301673A (en) * 1991-11-18 1994-04-12 Massachusetts General Hospital Ambulatory clearance function monitor
US5865763A (en) * 1996-08-13 1999-02-02 St. Luke's-Roosevelt Hospital Method for estimating creatinine clearance in obese and malnourished subjects using measurements of body cell mass
US7048907B2 (en) * 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
CA2544678C (en) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
GB0507838D0 (en) * 2005-04-18 2005-05-25 Epsom & St Helier University H A method of measuring the glomerular filtration rate of an human or animal patient, a self-use kit for providing blood samples for use in measuring glomerular
SI2444079T1 (sl) 2005-05-17 2017-05-31 Sarcode Bioscience Inc. Sestavki in postopki za zdravljenje očesnih motenj
EP2209371B1 (en) * 2007-10-19 2017-01-04 SARcode Bioscience Inc. Compositions and methods for treatment of diabetic retinopathy
EP2265124A4 (en) * 2008-04-15 2011-12-28 Sarcode Bioscience Inc AEROSOLISED LFA-1 ANTAGONISTS FOR THE USE IN THE LOCAL TREATMENT OF IMMUNE DISEASES
ES2763703T3 (es) * 2008-04-15 2020-05-29 Sarcode Bioscience Inc Antagonistas de LFA-1 tópicos utilizados en el tratamiento localizado de trastornos inmunes
US8080562B2 (en) 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US9085553B2 (en) 2012-07-25 2015-07-21 SARcode Bioscience, Inc. LFA-1 inhibitor and methods of preparation and polymorph thereof
CN103462886B (zh) * 2013-09-13 2015-05-13 四川鼎诺泰宸科技有限公司 稳定的左乙拉西坦注射液

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224641A1 (de) * 1982-07-01 1984-01-05 Walle Alexander Dr Verfahren zur bestimmung von glomerulaeren filtrationsraten

Also Published As

Publication number Publication date
EP0329961A2 (de) 1989-08-30
US4908202A (en) 1990-03-13
EP0329961A3 (en) 1990-10-31
JPH01226829A (ja) 1989-09-11
EP0329961B1 (de) 1992-06-24
DE58901722D1 (de) 1992-07-30
ATE77560T1 (de) 1992-07-15
DE3802996A1 (de) 1989-08-10

Similar Documents

Publication Publication Date Title
AR240048A1 (es) Derivados 5-oximicos de milbemicinas, excluidos su uso sobre o en seres humanos o animales superiores.
DE3882899D1 (de) Mehrschicht-kollimator und diesen verwendende vorrichtung.
DE68907553D1 (de) Make-up-mittel zur menschlichen anwendung.
BR8904419A (pt) Navalha de barbear ou navalha de desfiar
DE69013756D1 (de) Laserbehandlungsvorrichtung.
DE68909970D1 (de) Hautbehandlungsmittel.
ES2041845T3 (es) Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos.
ES519869A0 (es) Procedimiento y dispositivo para la limpieza de piezas individuales mecanizadas.
ES1016115Y (es) Aparato para determinar la velocidad de eritrosedimentacion y otros
NO164820C (no) Redningstrapp.
BR8706090A (pt) Dispositivo de tratamento de baixa frequencia orientado para utilizacao no banho
ES2018613B3 (es) Procedimiento y dispositivo para la depuracion de aguas contaminadas.
ES1022995Y (es) "estructura perfeccionada para la configuracion de faroles y similares".
NO930718L (no) Zona pellucida menneske-protein zp3
BR8906496A (pt) Barbeador aperfeicoado
ATE96020T1 (de) Hautbehandlungsmittel.
ES1016573Y (es) Estructura para la configuracion de faroles y similares.
NO881342L (no) Kosmetisk hudbehandling.
ES1014016Y (es) Dispositivo para aplicacion manual de masaje.
DK158789D0 (da) Koereskinne
ES1006787Y (es) Dispositivo para la higiene personal.
ES1008785Y (es) Instrumento para masajes.
ES1015421Y (es) Dispositivo para la sujecion y senalizacion de objetos.
BR7000623U (pt) Dispositivo para tratamento de unha
MX9102721A (es) Procedimento para la prepacion de arilquilaminas y arilquilaminas substituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 329961

Country of ref document: ES